ClinicalTrials.gg
RecruitingNCT07363694COPDUpdated Oct 22, 2026

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

A Phase 2/3 interventional study of PF-07275315 dose 1 and PF-07275315-dose 2 in Moderate to Severe Chronic Obstructive Pulmonary Disease, sponsored by Pfizer. Recruiting at 189 sites in 18 countries. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Pfizer · Phase 2/3, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Oct 22, 2026First sites in 8 new countriesSite recruiting status changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2/3
Study type
Interventional
Enrollment
1,156
Allocation
Randomized
Ages
35 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 22 studies in Pulmonary Disease, Chronic Obstructive by Pfizer — 2 open to participants now, 2 under way, 2 of them phase 3. Pulmonary Disease, Chronic Obstructive · Pfizer.

Planned enrollment
2nd of 19
1,156 · median 105
Started
2026
with 1 other
Phase 2/3
Only one
of the 22
Registered
21st of 22
by date

Among the 22 studies in Pulmonary Disease, Chronic Obstructive by Pfizer, this one is the 2nd largest by planned enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2026, is the only one in phase 2/3, and was the 21st registered.

Pulmonary Disease, Chronic Obstructive

5,523 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

2 of the 22 studies in Pulmonary Disease, Chronic Obstructive by Pfizer are open now, in 12 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Who these studies take

Of the 558 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 29 take children under 18; 88 take healthy volunteers.

This study: 35 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Pulmonary Disease, Chronic Obstructive by Pfizer, or all of them as a file.
02

Study summary

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected.

This study is seeking participants who:

  • Are 35 to 80 years old
  • Have had moderate-to-severe COPD for at least 12 months
  • Have a documented history of at least 2 moderate or severe exacerbations within the last 12 months
  • Have been continuously taking their regular maintenance treatment(s) for COPD over at least 6 months at a stable dose for 3 months

All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied.

PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 24 weeks for the Phase 2 part and 52 weeks for the Phase 3 part. We will compare the results of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective.

Participants who will be involved in the Phase 2 part of the study for about 40 weeks. During this time, they will have 11 visits at the study clinic.

Participants who will be involved in the Phase 3 part of the study for about 68 weeks. During this time, they will have 18 visits at the study clinic.

03

Conditions studied

  • Moderate to Severe Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
04

Who can participate

Ages eligible
35 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  • Diagnosis of (COPD) for at least 12 months (based on Global Initiative for Chronic Obstructive Lung Disease [GOLD] definition).
  • Spirometry values (post-bronchodilator [FEV1]/forced vital capacity [FVC] less than [\<] 70 percent (%) and post-bronchodilator FEV1 % predicted \<70%, but greater than equal to 30%).
  • Continuous treatment with standard of care triple therapy of LABA + LAMA + ICS for ≥ 6 months prior to Screening Visit 1 and at a stable dose for ≥3 months
  • Documented history of at least 2 moderate or severe ECOPD within the last 12 months prior to Screening.

Key Exclusion Criteria:

  • Significant pulmonary disease other than COPD.
  • Requirement for continuous chronic treatment with oxygen at >4.0 liters / minute by nasal cannula or equivalent.
  • Hypoxemia with a resting SpO2 \<88% while breathing ambient air (or on the participant's usual level of oxygen supplementation).
  • cardiovascular disease, acute and/or severe left heart failure, or heart failure partial , and/or cor pulmonale.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
1,156 participants (estimated)

Study arms

  • Experimental
    Phase 3 Treatment Arm A

    Drug: PF-07275315-dose 3

  • Experimental
    Phase 2 Treatment Arm B

    Drug: PF-07275315-dose 2

  • Experimental
    Phase 2 Treatment Arm A

    Drug: PF-07275315 dose 1

  • Placebo comparator
    Phase 3 Treatment Arm B

    Drug: Placebo

  • Placebo comparator
    Phase 2 Treatment Arm C

    Drug: Placebo

Interventions

06

What researchers measure

Primary outcomes

  1. Phase 2 part: Change from baseline in pre-bronchodilator Forced Expiratory Volume in 1 Second (FEV1) at Week 24

    FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration. FEV1 is obtained from spirometry.

    Time frame: Baseline to Week 24

  2. Phase 3 part: Annualized rate of moderate or severe ECOPD

    Exacerbation of Chronic Obstructive Pulmonary Disease (ECOPD) are sudden worsening of respiratory symptoms that significantly worsen lung function and quality of life.

    Time frame: Baseline to Week 52

Secondary outcomes

  1. Phase 2: Annualized rate of moderate or severe ECOPD.

    Time frame: Baseline to Week 24

  2. Phase 2: Change from baseline in pre-BD FEV1 up to Week 24.

    Time frame: Baseline to Week 24

  3. Phase 2: Change from baseline in trough, pre- and post-BD FEV1 up to Week 24

    Time frame: Baseline to Week 24

  4. Phase 2: Change from baseline in trough, pre- and post-BD FVC and FEV1/FVC ratio, % predicted FEV1, % predicted FVC up to Week 24.

    Time frame: Baseline to Week 24

  5. Phase 2: Change from baseline in trough FEV1 responsiveness to BD up to Week 24.

    Time frame: Baseline to Week 24

  6. Phase 2: Incidence and severity of TEAEs throughout Phase 2 part of the study.

    Time frame: Baseline to Week 24

  7. Phase 2: Incidence of treatment-emergent adverse events and serious adverse events leading to discontinuation.

    Time frame: Baseline to Week 24

  8. Phase 2: Incidence of clinical abnormalities in clinical laboratory values, ECG measurements, and vital signs.

    Time frame: Baseline to Week 24

  9. Phase 3: change from baseline in pre- and post-BD FEV1 at Week 12 and Week 52.

    Time frame: Baseline to Week 52

  10. Phase 3: Percentage of participants with ≥4 points improvement from baseline in Saint George's Respiratory Questionnaire (SGRQ) score at Week 52.

    Time frame: Baseline to Week 52

  11. Phase 3: Percentage of participants with ≥2 points improvement from baseline in the COPD Assessment Test (CAT) total score at Week 52.

    Time frame: Baseline to Week 52

  12. Phase 3: Percentage of participants with ≥2 points improvement from baseline in E-RS:COPD total score at Week 52.

    Time frame: Baseline to Week 52

  13. Phase 3: Annualized rate of severe ECOPD.

    Time frame: Baseline to Week 52

  14. Phase 2: Change from baseline of clinical abnormalities in clinical laboratory values, ECG measurements, and vital signs.

    Time frame: Baseline to Week 24

  15. Phase 3: Annualized rate of exacerbations requiring emergency department visit and/or hospitalization.

    Time frame: Baseline to Week 52

07

Study locations

160 of 189 sites recruiting
  • University of Alabama at Birmingham Lung Health Center
    Birmingham, Alabama 35233, United States
    Recruiting
  • SEC Clinical Research
    Dothan, Alabama 36305, United States
    Recruiting
  • Pulmonary Associates of Mobile, P.C.
    Mobile, Alabama 36608, United States
    Recruiting
  • Pulmonary Associates, PA
    Phoenix, Arizona 85027, United States
    Recruiting
  • IMAX Clinical Trials
    La Palma, California 90623, United States
    Recruiting
  • NewportNativeMD, Inc.
    Newport Beach, California 92663, United States
    Recruiting
  • California Medical Research Associates
    Northridge, California 91324, United States
    Recruiting
  • Institute of HealthCare Assessment d/b/a Apex Clinical Research
    San Diego, California 92120, United States
    Recruiting
  • Finlay Medical Research
    Greenacres City, Florida 33467, United States
    Recruiting
  • Clinical Research Specialists LLC
    Kissimmee, Florida 34746, United States
    Recruiting
  • Advanced Pulmonary Research Institute
    Loxahatchee Groves, Florida 33470, United States
    Recruiting
  • Reed Medical Research
    Miami, Florida 33176, United States
    Recruiting
  • Renstar Medical Research
    Ocala, Florida 34470, United States
    Recruiting
  • HCA Florida Ocala Imaging Center
    Ocala, Florida 34471, United States
    Recruiting
  • Ocala Lung and Critical Care Associates
    Ocala, Florida 34471, United States
    Recruiting
  • Renstar Medical Research
    Ocala, Florida 34471, United States
    Recruiting
  • Coastal Medical Research Institute, LLC
    St. Petersburg, Florida 33704, United States
    Recruiting
  • Coastal Pulmonary and Critical Care, P.L.C
    St. Petersburg, Florida 33704, United States
    Recruiting
  • Clinical Research Trials of Florida, Inc.
    Tampa, Florida 33607, United States
    Recruiting
  • Clinical Site Partners, LLC dba Flourish Research
    Winter Park, Florida 32789, United States
    Recruiting
  • Cpcc-Research Llc
    East Point, Georgia 30344, United States
    Recruiting
  • Centricity Research Rincon Pulmonology
    Rincon, Georgia 31326, United States
    Recruiting
  • ASHA Clinical Research - Munster, LLC
    Hammond, Indiana 46324, United States
    Recruiting
  • Methodist Hospital Southlake
    Merrillville, Indiana 46410, United States
    Recruiting
  • University of Kansas Medical Center
    Kansas City, Kansas 66160, United States
    Recruiting
  • Southern Clinical Research, LLC
    Zachary, Louisiana 70791, United States
    Recruiting
  • Paul A. Shapero, MD, PA
    Bangor, Maine 04401, United States
    Not yet recruiting
  • Exordia Medical Research Inc.
    Fall River, Massachusetts 02723, United States
    Recruiting
  • Infinity Medical Research
    North Dartmouth, Massachusetts 02747, United States
    Recruiting
  • Revival Research Institute, LLC
    Dearborn, Michigan 48126, United States
    Recruiting
  • AA Medical Research Center
    Flint, Michigan 48504, United States
    Recruiting
  • Revive Research Institute, Inc.
    Southfield, Michigan 48075, United States
    Recruiting
  • Oakland Medical Research
    Troy, Michigan 48085, United States
    Recruiting
  • Washington University School of Medicine
    St Louis, Missouri 63108, United States
    Recruiting
  • Barnes-Jewish Hospital Investigational Drug Service
    St Louis, Missouri 63110, United States
    Recruiting
  • Barnes-Jewish Hospital
    St Louis, Missouri 63110, United States
    Recruiting
  • Washington University School of Medicine
    St Louis, Missouri 63110, United States
    Recruiting
  • Washington University School-Cardiovascular Imaging and Clinical Research Core Laboratory
    St Louis, Missouri 63110, United States
    Recruiting
  • Henderson Clinical Trials
    Henderson, Nevada 89052, United States
    Recruiting
  • Northwell Health Physician Partners at Chappaqua
    Chappaqua, New York 10514, United States
    Not yet recruiting
  • New York Presbyterian Queens
    Flushing, New York 11355, United States
    Recruiting
  • Northern Westchester Hospital
    Mount Kisco, New York 10549, United States
    Not yet recruiting
  • Salem Chest Specialists
    Winston-Salem, North Carolina 27103, United States
    Recruiting
  • Southeastern Research Center
    Winston-Salem, North Carolina 27103, United States
    Recruiting
  • Toledo Institute of Clinical Research Inc.
    Toledo, Ohio 43617, United States
    Recruiting
  • Layrek Clinical Research
    Tulsa, Oklahoma 74133, United States
    Recruiting
  • Clinical Research Associates of Central PA, LLC
    DuBois, Pennsylvania 15801, United States
    Recruiting
  • Temple University Hospital
    Philadelphia, Pennsylvania 19140, United States
    Not yet recruiting
  • Temple Health Oaks
    Phoenixville, Pennsylvania 19460, United States
    Not yet recruiting
  • Bogan Sleep Consultants, LLC
    Columbia, South Carolina 29201, United States
    Recruiting
  • Velocity Clinical Research, Gaffney
    Gaffney, South Carolina 29340, United States
    Recruiting
  • Clinical Research of Rock Hill
    Rock Hill, South Carolina 29732, United States
    Recruiting
  • Velocity Clinical Research, Spartanburg
    Spartanburg, South Carolina 29303, United States
    Recruiting
  • Health Concepts
    Rapid City, South Dakota 57702, United States
    Recruiting
  • Clinical Trials Center of Middle Tennessee, LLC
    Franklin, Tennessee 37067, United States
    Recruiting
  • Premier Research Center, LLC
    Hendersonville, Tennessee 37075, United States
    Recruiting
  • South Texas Medical Research Institute, Inc., DBA TTS Research
    Boerne, Texas 78006, United States
    Recruiting
  • Ten20 Clinical Research
    Carrollton, Texas 75010, United States
    Recruiting
  • Horizon Clinical Research Group
    Cypress, Texas 77429, United States
    Recruiting
  • Alina Clinical Trials, LLC.
    Dallas, Texas 75209, United States
    Recruiting
  • Baylor Scott & White Advanced Lung Disease Specialists
    Dallas, Texas 75246, United States
    Recruiting
  • Baylor University Medical Center (Research Office)
    Dallas, Texas 75246, United States
    Recruiting
  • Baylor University Medical Center
    Dallas, Texas 75246, United States
    Recruiting
  • Greater Heights & Memorial Pulmonary and Sleep
    Houston, Texas 77008, United States
    Recruiting
  • Houston Pulmonary Sleep and Allergy Associates
    Houston, Texas 77065, United States
    Recruiting
  • Sherman Clinical Research
    Sherman, Texas 75090, United States
    Recruiting
  • IDIM - Instituto de Investigaciones Metabólicas
    Ciudad Autonoma de Buenos Aires, Buenos Aires C1012AAR, Argentina
    Recruiting
  • Centro Médico Dra. De Salvo - Fundación Respirar
    Ciudad Autonoma de Buenos Aires, Buenos Aires C1426ABP, Argentina
    Recruiting
  • Centro de Investigaciones Médicas Mar del Plata
    Mar del Plata, Buenos Aires 7600, Argentina
    Recruiting
  • Instituto Médico DAMIC
    Córdoba, Córdoba Province X5003DCE, Argentina
    Recruiting
  • Instituto de Salud Respiratoria - (INSARES)
    Mendoza, Mendoza Province 5500, Argentina
    Recruiting
  • Fundación Grupo Colaborativo Rosario Investigación y Prevención Médica
    Rosario, Santa Fe Province 2000, Argentina
    Recruiting
  • Westmead Hospital
    Westmead, New South Wales 2145, Australia
    Not yet recruiting
  • Mater Misericordiae Limited
    South Brisbane, Queensland 4101, Australia
    Not yet recruiting
  • Monash Health
    Clayton, Victoria 3168, Australia
    Not yet recruiting
  • TrialsWest - Spearwood
    Spearwood, Western Australia 6163, Australia
    Recruiting
  • Medical Center Pulmo - 2018 EOOD
    Haskovo, Haskovo 6300, Bulgaria
    Recruiting
  • Specialized Hospital for Active Treatment of Lung Diseases - Sv. Panteleymon EOOD
    Pernik, Pernik 2300, Bulgaria
    Recruiting
  • SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD
    Rousse, Ruse 7002, Bulgaria
    Recruiting
  • MHAT Knyaginya Klementina - Sofia EAD
    Sofia, Sofia 1233, Bulgaria
    Recruiting
  • Medical Center Hera EOOD
    Sofia, Sofia (stolitsa) 1510, Bulgaria
    Recruiting
  • Medical Center New Rehabilitation Center EOOD
    Stara Zagora, Stara Zagora 6001, Bulgaria
    Recruiting
  • Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Dr. Treiman
    Veliko Tarnovo, Veliko Tarnovo 5000, Bulgaria
    Recruiting
  • MHAT "Sveta Ekaterina" Dimitrovgrad
    Dimitrovgrad, 6400, Bulgaria
    Recruiting
  • Medical Center Fama Medical
    Plovdiv, Bulgaria
    Recruiting
  • Fifth MHAT EAD
    Sofia, 1233, Bulgaria
    Recruiting
  • Synergy Respiratory Care
    Sherwood Park, Alberta T8H 0N2, Canada
    Recruiting
  • Dr. Syed Anees Medicine Professional Corporation
    Windsor, Ontario N8X 1T3, Canada
    Recruiting
  • Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (IUCPQ-UL)
    Québec, Quebec G1V 4G5, Canada
    Recruiting
  • C.I.C. Mauricie inc.
    Trois-Rivières, Quebec G8T 7A1, Canada
    Not yet recruiting
  • The People's Hospital of Chizhou
    Chizhou, Anhui 247000, China
    Recruiting
  • Fuyang People's Hospital
    Fuyang, Anhui 236000, China
    Recruiting
  • Anhui Chest Hospital
    Hefei, Anhui 230022, China
    Recruiting
  • China-Japan Friendship Hospital
    Beijing, Beijing Municipality 100029, China
    Recruiting
  • Chongqing Red Cross Hospital (Jiangbei District People's Hospital)
    Chongqing, Chongqing Municipality 400000, China
    Recruiting
  • The Third Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong 510150, China
    Recruiting
  • Huizhou Central People's Hospital
    Huizhou, Guangdong 516001, China
    Recruiting
  • The First People's Hospital of Xinxiang
    Xinxiang, Henan 453000, China
    Recruiting
  • The Central Hospital of Wuhan
    Wuhan, Hubei 430024, China
    Recruiting
  • The First Hospital of Changsha
    Changsha, Hunan 410005, China
    Recruiting

Showing the first 100 of 189 sites across 18 countries. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: Yes — Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Data sharing details ↗ · www.pfizer.com

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Oct 2030, 56 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2026
First posted
Jan 23, 2026
StartActual
Feb 11, 2026
Primary completionEst.
Oct 24, 2030
CompletionEst.
Jan 16, 2031
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
76 sites added, 7 sites removed — first sites in Australia, Bulgaria, France, Germany, Italy and 3 more
All 8 countries

Australia, Bulgaria, France, Germany, Italy, Poland, Spain, United Kingdom

. 15 sites changed recruiting status (15 now recruiting)
Show 15 sites
  • University of Kansas Medical Center · Kansas City, United StatesNot yet recruiting→Recruiting
  • Exordia Medical Research Inc. · Fall River, United StatesNot yet recruiting→Recruiting
  • Infinity Medical Research · North Dartmouth, United StatesNot yet recruiting→Recruiting
  • New York Presbyterian Queens · Flushing, United StatesNot yet recruiting→Recruiting
  • Toledo Institute of Clinical Research Inc. · Toledo, United StatesNot yet recruiting→Recruiting
  • The People's Hospital of Chizhou · Chizhou, ChinaNot yet recruiting→Recruiting
  • Fuyang People's Hospital · Fuyang, ChinaNot yet recruiting→Recruiting
  • Anhui Chest Hospital · Hefei, ChinaNot yet recruiting→Recruiting
  • China-Japan Friendship Hospital · Beijing, ChinaNot yet recruiting→Recruiting
  • Huizhou Central People's Hospital · Huizhou, ChinaNot yet recruiting→Recruiting
  • The Affiliated Hospital of Inner Mongolia Medical University · Hohhot, ChinaNot yet recruiting→Recruiting
  • The Affiliated Hospital of Xuzhou Medical College · Xuzhou, ChinaNot yet recruiting→Recruiting
  • Shanghai Tongji Hospital · Shanghai, ChinaNot yet recruiting→Recruiting
  • MUDr.I. Cierna Peterova s.r.o. · Brandýs nad Labem-Stará Boleslav, CzechiaNot yet recruiting→Recruiting
  • Erzsebet Gondozohaz · Gödöllő, HungaryNot yet recruiting→Recruiting
Show 76 added (10 Bulgaria, 8 United Kingdom, 7 Poland, 6 United States, 6 Germany, 5 Italy, 5 Spain, 4 Argentina, 4 Australia, 4 China, 4 France, 4 Hungary, 3 Czechia, 3 Taiwan, 1 Canada, 1 India, 1 Japan)
  • Layrek Clinical Research · Tulsa, United States
  • Temple University Hospital · Philadelphia, United States
  • Temple Health Oaks · Phoenixville, United States
  • Baylor Scott & White Advanced Lung Disease Specialists · Dallas, United States
  • Baylor University Medical Center (Research Office) · Dallas, United States
  • Baylor University Medical Center · Dallas, United States
  • Centro de Investigaciones Médicas Mar del Plata · Mar del Plata, Argentina
  • Instituto Médico DAMIC · Córdoba, Argentina
  • Instituto de Salud Respiratoria - (INSARES) · Mendoza, Argentina
  • Fundación Grupo Colaborativo Rosario Investigación y Prevención Médica · Rosario, Argentina
  • Westmead Hospital · Westmead, Australia
  • Mater Misericordiae Limited · South Brisbane, Australia
  • Monash Health · Clayton, Australia
  • TrialsWest - Spearwood · Spearwood, Australia
  • Medical Center Pulmo - 2018 EOOD · Haskovo, Bulgaria
  • Specialized Hospital for Active Treatment of Lung Diseases - Sv. Panteleymon EOOD · Pernik, Bulgaria
  • SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD · Rousse, Bulgaria
  • MHAT Knyaginya Klementina - Sofia EAD · Sofia, Bulgaria
  • Medical Center Hera EOOD · Sofia, Bulgaria
  • Medical Center New Rehabilitation Center EOOD · Stara Zagora, Bulgaria
  • Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Dr. Treiman · Veliko Tarnovo, Bulgaria
  • MHAT "Sveta Ekaterina" Dimitrovgrad · Dimitrovgrad, Bulgaria
  • Medical Center Fama Medical · Plovdiv, Bulgaria
  • Fifth MHAT EAD · Sofia, Bulgaria
  • Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (IUCPQ-UL) · Québec, Canada
  • Chongqing Red Cross Hospital (Jiangbei District People's Hospital) · Chongqing, China
  • The Central Hospital of Wuhan · Wuhan, China
  • The First Hospital of Changsha · Changsha, China
  • The Second Xiangya Hospital of Central South University · Changsha, China
  • Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje · Mladá Boleslav, Czechia
  • …and 46 more on the registry record
Show 7 removed
  • Chandler Clinical Trials · Chandler, United States
  • Instituto de Salud Respiratoria - (INSARES) · Mendoza, Argentina
  • Jawahar Lal Nehru Medical College · Ajmer, India
  • Hiroshima Prefectural Hospital · Hiroshima, Japan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City, Taiwan
  • Taichung Veterans General Hospital · Taichung, Taiwan
  • Chang Gung Medical Foundation-Linkou Branch · Taoyuan, Taiwan
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    76 sites added, 7 sites removed — first sites in Australia, Bulgaria, France, Germany, Italy and 3 more
    All 8 countries

    Australia, Bulgaria, France, Germany, Italy, Poland, Spain, United Kingdom

    . 15 sites changed recruiting status (15 now recruiting)
    Show 15 sites
    • University of Kansas Medical Center · Kansas City, United StatesNot yet recruiting→Recruiting
    • Exordia Medical Research Inc. · Fall River, United StatesNot yet recruiting→Recruiting
    • Infinity Medical Research · North Dartmouth, United StatesNot yet recruiting→Recruiting
    • New York Presbyterian Queens · Flushing, United StatesNot yet recruiting→Recruiting
    • Toledo Institute of Clinical Research Inc. · Toledo, United StatesNot yet recruiting→Recruiting
    • The People's Hospital of Chizhou · Chizhou, ChinaNot yet recruiting→Recruiting
    • Fuyang People's Hospital · Fuyang, ChinaNot yet recruiting→Recruiting
    • Anhui Chest Hospital · Hefei, ChinaNot yet recruiting→Recruiting
    • China-Japan Friendship Hospital · Beijing, ChinaNot yet recruiting→Recruiting
    • Huizhou Central People's Hospital · Huizhou, ChinaNot yet recruiting→Recruiting
    • The Affiliated Hospital of Inner Mongolia Medical University · Hohhot, ChinaNot yet recruiting→Recruiting
    • The Affiliated Hospital of Xuzhou Medical College · Xuzhou, ChinaNot yet recruiting→Recruiting
    • Shanghai Tongji Hospital · Shanghai, ChinaNot yet recruiting→Recruiting
    • MUDr.I. Cierna Peterova s.r.o. · Brandýs nad Labem-Stará Boleslav, CzechiaNot yet recruiting→Recruiting
    • Erzsebet Gondozohaz · Gödöllő, HungaryNot yet recruiting→Recruiting
    Show 76 added (10 Bulgaria, 8 United Kingdom, 7 Poland, 6 United States, 6 Germany, 5 Italy, 5 Spain, 4 Argentina, 4 Australia, 4 China, 4 France, 4 Hungary, 3 Czechia, 3 Taiwan, 1 Canada, 1 India, 1 Japan)
    • Layrek Clinical Research · Tulsa, United States
    • Temple University Hospital · Philadelphia, United States
    • Temple Health Oaks · Phoenixville, United States
    • Baylor Scott & White Advanced Lung Disease Specialists · Dallas, United States
    • Baylor University Medical Center (Research Office) · Dallas, United States
    • Baylor University Medical Center · Dallas, United States
    • Centro de Investigaciones Médicas Mar del Plata · Mar del Plata, Argentina
    • Instituto Médico DAMIC · Córdoba, Argentina
    • Instituto de Salud Respiratoria - (INSARES) · Mendoza, Argentina
    • Fundación Grupo Colaborativo Rosario Investigación y Prevención Médica · Rosario, Argentina
    • Westmead Hospital · Westmead, Australia
    • Mater Misericordiae Limited · South Brisbane, Australia
    • Monash Health · Clayton, Australia
    • TrialsWest - Spearwood · Spearwood, Australia
    • Medical Center Pulmo - 2018 EOOD · Haskovo, Bulgaria
    • Specialized Hospital for Active Treatment of Lung Diseases - Sv. Panteleymon EOOD · Pernik, Bulgaria
    • SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD · Rousse, Bulgaria
    • MHAT Knyaginya Klementina - Sofia EAD · Sofia, Bulgaria
    • Medical Center Hera EOOD · Sofia, Bulgaria
    • Medical Center New Rehabilitation Center EOOD · Stara Zagora, Bulgaria
    • Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Dr. Treiman · Veliko Tarnovo, Bulgaria
    • MHAT "Sveta Ekaterina" Dimitrovgrad · Dimitrovgrad, Bulgaria
    • Medical Center Fama Medical · Plovdiv, Bulgaria
    • Fifth MHAT EAD · Sofia, Bulgaria
    • Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (IUCPQ-UL) · Québec, Canada
    • Chongqing Red Cross Hospital (Jiangbei District People's Hospital) · Chongqing, China
    • The Central Hospital of Wuhan · Wuhan, China
    • The First Hospital of Changsha · Changsha, China
    • The Second Xiangya Hospital of Central South University · Changsha, China
    • Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje · Mladá Boleslav, Czechia
    • …and 46 more on the registry record
    Show 7 removed
    • Chandler Clinical Trials · Chandler, United States
    • Instituto de Salud Respiratoria - (INSARES) · Mendoza, Argentina
    • Jawahar Lal Nehru Medical College · Ajmer, India
    • Hiroshima Prefectural Hospital · Hiroshima, Japan
    • Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City, Taiwan
    • Taichung Veterans General Hospital · Taichung, Taiwan
    • Chang Gung Medical Foundation-Linkou Branch · Taoyuan, Taiwan
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07363694
Lead sponsor
Pfizer
Responsible party
Sponsor
First posted
Jan 23, 2026
Start date
Feb 11, 2026
Primary completion
Oct 24, 2030 (estimated)
Completion
Jan 16, 2031 (estimated)
Last update
Oct 22, 2026

Study contacts

Pfizer CT.gov Call Center
Contact
ClinicalTrials.gov_Inquiries@pfizer.com
1-800-718-1021
Pfizer CT.gov Call Center
study director · Pfizer

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tilrekimig

Start the discussion